MAPT and tauopathy: The fact that the heterozygous parents of these individuals are healthy, however, is encouraging, and partial reduction of TYK2 via viral infection of Tyk2 shRNA was sufficient to reduce tau levels and mitigate astrogliosis and microgliosis seen in tauopathy mouse models.